You have successfully logged out.

Hello !
Logout

Skin care

Skin breakdown and scar formation

Clinicians often play a key role in the prevention and early detection of skin disorders. First-line prevention is recommended before these complicated problems occur.1 But also in later stages of the wound-healing process, preventive measures like a structured scar management can effectively limit unnecessary scar formation in most cases. If formation of excessive scar tissues can be prevented it can be vital for the patients’ well-being.2

green and purple waterdrop illustration

incontinence green illustration

purple pie chart

Linovera® Emulsion

Chronic wounds are a major global medical concern,1 significantly impacting patients’ quality of life,2 while also affecting close family and relatives. Chronic wounds also cause considerable financial burden3 on the healthcare system and society.Topical preventive measures such as Linovera® Emulsion are needed to avoid higher healthcare expenditures and preserve patients’ health. They can be used with the goal of promoting integrity of the skin and providing essential moisturizing.4HOFA-containing topical formulations have become an ideal therapeutic option that is part of the clinical protocols for nursing action in the prevention and treatment of ulcers.5Linovera® Emulsion is a light emulsion moisturizing cream composed of:Hyperoxygenated fatty acids (HOFA) originated from sunflower oil naturally rich in linoleic acid,6 an essential fatty acid important in the maintenance of epidermal integrity and the natural skin’s water barrier.7 Some of the HOFA properties can increase skin resistance, reduce dehydration, reduce friction and pressure forces8 and improve microcirculation.9  Vegetable extracts formulated to provide additional benefits such as skin conditioning, humectant and tonic, enhancing the activity of the product.How Linovera® Emulsion can be usedThanks to its content of HOFA and vegetable extracts, Linovera® Emulsion can be useful in the prevention of skin breakdown (e.g. pressure ulcers, vascular ulcers, and diabetic foot ulcers) or in the management of already impaired skin8,10 helping to provide the best care for your patients.With its creamy consistency, Linovera® Emulsion is easy to apply on large body areas, such as limbs and feet11.CompositionHyperoxygenated fatty acids derived from sunflower oil (emollient)Aloe Barbadensis extract (skin conditioning, emollient, humectant)Asian Centella oil extract (skin conditioning, skin tonic, soothing agent)Rosemary essential oil (organoleptic)Ginkgo biloba (skin conditioning)IndicationsLinovera® Emulsion is indicated: For patients whose skin integrity is at riskFor prevention of pressure ulcers, vascular ulcers and diabetic foot ulcersFor treatment of stage 1  pressure ulcersFor large skin surfaces, such as whole lower limbs

Askina® Stick®

Linovera®

Chronic wounds are a major global medical concern,1 significantly impacting patients’ quality of life,2 while also affecting close family and relatives. Chronic wounds also cause considerable financial burden3 on the healthcare system and society.Topical preventive measures such as Linovera® oil are needed to avoid higher healthcare expenditures and preserve patients’ health. They can be used with the goal of promoting integrity of the skin and providing essential moisturizing.4HOFA-containing topical formulations have become an ideal therapeutic option that is part of the clinical protocols for nursing action in the prevention and treatment of ulcers.5 Linovera® is a skin care oil composed of: Hyperoxygenated fatty acids (HOFA) originated from sunflower oil naturally rich in linoleic acid,6 an essential fatty acid important in the maintenance of epidermal integrity and the natural skin’s water barrier.7 Some of the HOFA properties can increase skin resistance, reduce dehydration, reduce friction and pressure forces8 and improve microcirculation.9Vegetable extracts formulated to provide additional benefits such as skin conditioning, humectant, and tonic, enhancing the activity of the product. Thanks to its content of HOFA and vegetable extracts, Linovera® oil can be useful in the prevention of skin breakdown (e.g. prevention of stage 1 pressure ulcers) or in the management of already impaired skin,8,10 helping to provide the best care for your patients. CompositionHyperoxygenated fatty acids derived from sunflower oil (emollient)Aloe Barbadensis extract (skin conditioning, emollient, humectant)Asian Centella oil extract (skin conditioning, skin tonic, soothing agent)Rosemary essential oil (organoleptic) IndicationsLinovera® oil is indicated: For patients whose skin integrity is at riskFor prevention of pressure ulcers, vascular ulcers and diabetic foot ulcersFor treatment of stage 1 pressure ulcers

Askina® Barrier Cream

Askina® Barrier Cream is a white concentrated cream that provides protection to skin from body fluids. It protects dry, chafed, red, or irritated skin by moisturizing the skin and providing a long-lasting barrier.(1)

Askina® Barrier Film Swabs

Askina® Barrier Film Swabs are sterile foam applicators with a polymeric solution which offer between 48-72h of protection to intact or damaged skin. The non-stinging solvent forms a uniform film when applied to the skin. It is a multiple use device that is intended for single patient use.(1) 

green illustration people with scars

scar illustration

Askina® Scar Repair

Askina® Scar Repair is a thin, flexible, comfortable soft silicone dressing for scar management. The dressing is designed for recently closed wounds to prevent abnormal scarring.  It also can be used for the treatment of already formed hypertrophic and keloid scars (C-sections, tummy tucks, injuries, burns, surgeries, etc.) to help with scar reduction. Silicone is widely used in scar management due to its numerous benefits:Hydration: Silicone dressings maintain a hydrated environment for the scar, which is essential for proper healing. This hydration helps the scars to become lighter, more pliable, and flatter, making them less noticeable.1Silicone can reduce the production of collagen fibers, which helps in preventing the formation of hypertrophic and keloid scars.2Symptom relief: Silicone can alleviate symptoms such as itchiness and discomfort associated with scars.2Askina® Scar Repair is a repositionable, waterproof dressing that can be worn continuously for 24 hours and removed once a day when showering or bathing to inspect and wash the skin. It also provides UV protection. Silicone adhesive allows a painless removal of the dressing, and the same dressing can be used for 3 to 7 days. 

Linovera® Scar Repair

Linovera® Scar Repair is a gel with hyaluronic acid which improves the process of natural scar tissue maturation with good esthetic results. The properties of Linovera® Scar Repair’s components, hyaluronic acid, extracts of Centella Asiatica and Syricalm, improve skin hydration,relieve unpleasant sensations such as itchiness and tightness, andmake scars softer and flatter. Early and continuous application after wound healing can positively influence the maturation process of the scar tissue and contribute to prevent the formation of hypertrophic and keloid scars.

References

  1. Banharak S, Panpanit L, Subindee S, Narongsanoi P, Sanun-Aur P, Kulwong W, Songtin P, Khemphimai W. Prevention and Care for Incontinence-Associated Dermatitis Among Older Adults: A Systematic Review. J Multidiscip Healthc. 2021 Oct 26;14:2983-3004. doi: 10.2147/JMDH.S329672. PMID: 34729012; PMCID: PMC8556723.
  2. Roseborough IE, Grevious MA, Lee RC. Prevention and treatment of excessive dermal scarring. J Natl Med Assoc. 2004 Jan;96(1):108-16. PMID: 14746360; PMCID: PMC2594768.
  3. Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, Gray M, Woodward S, Fader M, Van den Bussche K, Van Hecke A, De Meyer D, Verhaeghe S. Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD011627. doi:10.1002/14651858.CD011627.pub2. PMID: 27841440; PMCID: PMC6464993.
  4. Gray M, Beeckman D, Bliss DZ, Fader M, Logan S, Junkin J, Selekof J, Doughty D, Kurz P. Incontinence-associated dermatitis: a comprehensive review and update. J Wound Ostomy Continence Nurs. 2012 Jan-Feb;39(1):61-74. doi: 10.1097/WON.0b013e31823fe246. PMID: 22193141.
  5. Sund B. New Developments in Wound Care. First Edition. London: PJB Publications; 2000. pp. 1–255
  6. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011 Jan-Feb;17(1-2):113-25. doi: 10.2119/molmed.2009.00153. Epub 2010 Oct 5. PMID: 20927486; PMCID: PMC3022978.